Use quotation marks("") to search for exact phrase or group of words
e.g. "breakbone fever"
Use "OR" to get either results
Placing "OR" in between your keywords gives you more results
e.g. dengue OR "breakbone fever"
Use "NOT" to exclude words
e.g. health care service NOT in manila
A Phase 3, randomized, stratified, observer-blind, active-controlled study to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults 18 years and older
This is a Phase 3, randomized, stratified, observer-blind, active-controlled study to evaluate the immunogenicity and safety of mRNA-1010 vaccine in preventing seasonal influenza in adults aged 18 years and older.
A Global Study to Assess the Effects of Durvalumab +Domvanalimab Following Concurrent Chemoradiation in Patients with Stage III Unresectable Non-Small Cell LungCancer (PACIFIC 8)
PFS is defined as time from randomisation until progression per RECIST1.1 as assessed by BICR, or death due to any cause
•PFS measured by HR
Locally advanced (Stage III), unresectable Non-small cell lung cancer
A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH)
INNOVATE- Inovio INO-4800 Vaccine Trial for Efficacy
Safety and Pharmacodynamics of Repeat Doses of ANX009 SC in Participants with Lupus Nephritis
Primary Endpoint : Number and percentage of participants with treatment-emergent adverse events (TEAEs)
Men and women aged 18 to75 years old who have been diagnosed with Lupus Nephritis
Safety and immunogenicity of Recombinant COVID-19 vaccine as a booster following primary vaccination of either Inactivated or mRNA or Viral Vector COVID-19 vaccines: A phase II observer-blind, randomized, controlled, investigator-initiated clinical trial
Prevention of COVID-19 caused by infection with the SARS-CoV-2.
Mindfulness-Based Self-Compassion Therapy as an Adjunct Treatment for Moderate to Severe Chronic Plaque Psoriasis: A Randomized Control Trial
Psoriasis Area Severity Index
Dermatology Life Quality Index
Chronic Plaque Psoriasis
A 5-year study to test BI 655130 in patients with Generalized Pustular Psoriasis who took part in previous studies with BI 655130
Primary objective: to evaluate the long-term safety and efficacy of BI 655130 in patients with GPP, who have completed previous BI 655130 trials
Primary endpoint: occurrence of treatment emergent adverse events (TEAEs) up to week 252 of maintenance treatment.
Generalized Pustular Psoriasis (GPP)
A Multi-center, Observer-blind, Randomized, Controlled Phase 3 Study to Evaluate the Immunogenicity and Safety of Adjuvanted Recombinant SARS-CoV-2 Trimeric Sprotein Subunit Vaccine (SCB-2019), Administered as a Booster Dose to Adults, who Previously Received Primary Series of a COVID-19 Vaccine
The primary endpoints are SARS-CoV-2-neutralization titers at Day 15 in SCB-2019 booster recipients and recipients of a homologous booster vaccine within each primary vaccination group (Comirnaty,COVID-19 Vaccine Janssen, and CoronaVac).
Effectiveness of Simplified Negative Wound Pressure Therapy in Wound Healing of Diabetic Foot Ulcers: A Randomized Control Study.
Diabetic foot ulcers